Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 4 (2007), Issue 10 (October)

1. Marijuana use motives: A confirmatory test and evaluation among young adult marijuana users.
   Addict Behav, 32(12): 3122-30. [Abstract] [Full-text]
2. Predictors of cannabis use in men with and without psychosis.
   Addict Behav, 32(12): 2879-87. [Abstract] [Full-text]
3. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
   Eur J Pharmacol, 573(1): 11-9. [Abstract] [Full-text]
4. Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance.
   Neuropsychol Rev, 17(3): 347-61. [Abstract] [Full-text]
5. Childhood characteristics associated with stage of substance use of American Indians: Family background, traumatic experiences, and childhood behaviors.
   Addict Behav, 32(12): 3142-52. [Abstract] [Full-text]
6. Marijuana use, risk perception, and consequences: is perceived risk congruent with reality?
   Addict Behav, 32(12): 3026-33. [Abstract] [Full-text]
7. Perceived availability, risks, and benefits of gambling among college students.
   J Gambl Stud, 23(4): 395-408. [Abstract] [Full-text]
8. Effects of prenatal cocaine exposure on growth: a longitudinal analysis.
   Pediatrics, 120(4): e1017-27. [Abstract] [Full-text]
9. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
   Arch Gen Psychiatry, 64(10): 1145-52. [Abstract] [Full-text]
10. The prevalence and significance of substance use disorders in bipolar type I and II disorder.
    Subst Abuse Treat Prev Policy, 2(1): 29. [Abstract] [Full-text]
11. Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice.
    Behav Pharmacol, 18(7): 691-7. [Abstract] [Full-text]
12. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
    Basic Clin Pharmacol Toxicol, 101(5): 287-93. [Abstract] [Full-text]
13. Quality of chemically modified hemp fibers.
    Bioresour Technol, 99(1): 94-9. [Abstract] [Full-text]
14. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.
    Schizophr Res, 96(1): 169-84. [Abstract] [Full-text]
15. Parent-Child Acculturation Discrepancies as a Risk Factor for Substance Use among Hispanic Adolescents in Southern California.
    J Immigr Minor Health. [Abstract] [Full-text]
16. Sexual behaviors and their correlates among young people in Mauritius: a cross-sectional study.
    BMC Int Health Hum Rights, 7(1): 8. [Abstract] [Full-text]
17. New directions in the conceptualization of psychotic disorders.
    Curr Opin Psychiatry, 20(6): 573-7. [Abstract] [Full-text]
18. A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex.
    Brain Res, 1175: 39-47. [Abstract] [Full-text]
19. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
    Aust N Z J Psychiatry, 41(11): 934-6. [Abstract] [Full-text]
20. The Neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Aust N Z J Psychiatry, 41(11): 869-84. [Abstract] [Full-text]
21. Self-reported racial discrimination and substance use in the Coronary Artery Risk Development in Adults Study.
    Am J Epidemiol, 166(9): 1068-79. [Abstract] [Full-text]
22. Illicit drug use and neonatal outcomes: a critical review.
    Obstet Gynecol Surv, 62(11): 749-57. [Abstract] [Full-text]
23. Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels.
    Expert Opin Pharmacother, 8(14): 2207-13. [Abstract] [Full-text]
24. Continuity, psychosocial correlates, and outcome of problematic substance use from adolescence to young adulthood in a community sample.
    Child Adolesc Psychiatry Ment Health, 1(1): 12. [Abstract] [Full-text]
25. Predictors of marijuana use among married couples: the influence of one's spouse.
    Drug Alcohol Depend, 91(2): 121-8. [Abstract] [Full-text]
26. Comparative toxicology of fatal heroin overdose cases and morphine positive homicide victims.
    Addiction, 102(11): 1793-7. [Abstract] [Full-text]
27. Peer acceleration: effects of a social network tailored substance abuse prevention program among high-risk adolescents.
    Addiction, 102(11): 1804-15. [Abstract] [Full-text]
28. Delta9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Acta Oncol. [Abstract] [Full-text]
29. Images of sexual stereotypes in rap videos and the health of African American female adolescents.
    J Womens Health (Larchmt), 16(8): 1157-64. [Abstract] [Full-text]
30. Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior.
    Neuropsychopharmacology, 32(11): 2260-6. [Abstract] [Full-text]
31. Replacing ineffective early alcohol/drug education in the United States with age-appropriate adolescent programmes and assistance to problematic users.
    Drug Alcohol Rev, 26(6): 577-84. [Abstract] [Full-text]
32. Cannabis, the mind and society: the hash realities.
    Nat Rev Neurosci, 8(11): 885-95. [Abstract] [Full-text]
33. Vaporization as a smokeless cannabis delivery system: a pilot study.
    Clin Pharmacol Ther, 82(5): 572-8. [Abstract] [Full-text]
34. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.
    J Neurosci, 27(43): 11700-11. [Abstract] [Full-text]
35. Substance use and abuse in first-episode psychosis: prevalence before and after early intervention.
    Schizophr Bull, 33(6): 1354-63. [Abstract] [Full-text]
36. Long-term impact of adolescent dating violence on the behavioral and psychological health of male and female youth.
    J Pediatr, 151(5): 476-81. [Abstract] [Full-text]
37. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.
    Br J Pharmacol, 152(5): 624-32. [Abstract] [Full-text]
38. Cannabinoid control of neuroinflammation related to multiple sclerosis.
    Br J Pharmacol, 152(5): 649-54. [Abstract] [Full-text]
39. Cannabis reward: biased towards the fairer sex?
    Br J Pharmacol, 152(5): 562-4. [Abstract] [Full-text]
40. Condom use among unmarried students in a Hispanic-serving university.
    AIDS Educ Prev, 19(5): 448-61. [Abstract] [Full-text]
41. Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats.
    Int J Neuropsychopharmacol, 10(6): 727-39. [Abstract] [Full-text]
42. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
    Int J Androl. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.